Bio-Techne Launches Cultrex™ Synthetic Hydrogel to Enhance Reproducibility in 3D Organoid Culture
Exhibitor: HONG JING CO., LTD.
Date: 2026-05-11
Booth No.: M1028
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Bio-Techne announced the launch of Cultrex™ Synthetic Hydrogel, a fully defined synthetic extracellular matrix (ECM), expanding its established Cultrex™ ECM portfolio and providing researchers with a more reproducible and scalable solution for 3D stem cell and organoid culture workflows.
Cultrex™ Synthetic Hydrogel is designed to reduce lot-to-lot variability commonly associated with traditional biologically derived matrices. By offering a fully defined composition, it enables more consistent experimental conditions across studies and laboratories, improving reproducibility and data reliability in 3D culture systems.
The product supports a broad range of organoid applications, including drug screening, toxicology studies, and personalized medicine research, while reducing reliance on animal-derived matrices and supporting the adoption of New Approach Methodologies (NAMs).
From a regulatory perspective, Cultrex™ Synthetic Hydrogel aligns with FDA initiatives aimed at improving translational predictability by enabling more robust and standardized preclinical models. Its defined composition supports consistency, traceability, and scalability for workflows advancing toward regulatory-facing studies.
Will Geist, President of the Protein Sciences Segment at Bio-Techne, commented:
“This product reflects the evolving needs of researchers as stem cell and organoid models move more quickly from discovery into translational workflows. Cultrex™ Synthetic Hydrogel expands our ECM portfolio with a fully defined, scalable solution that enhances reproducibility and consistency without compromising performance.”
This launch further strengthens Bio-Techne’s comprehensive Cultrex™ portfolio, which includes Basement Membrane Extracts (BME), recombinant proteins, cytokines and growth factors, AI-modified proteins, small molecules, media, and supplements—offering researchers a complete toolbox for 3D culture applications.
As the authorized Bio-Techne distributor in Taiwan, HongJin Co., Ltd. continues to support local researchers with Cultrex™ ECM products and 3D stem cell and organoid culture solutions, providing technical support and application guidance to accelerate research in regenerative medicine, drug discovery, and translational science.
More Exhibitor's Press Release
- LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025 LABWARE TAIWAN CO., LTD. / 2026-06-22
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser EG BIOMED US INC. / 2026-06-15
- Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science EG BIOMED US INC. / 2026-06-15
- EG BioMed U.S. CLIA/CAP-Certified Laboratory Opens Partnership Opportunities EG BIOMED US INC. / 2026-06-15
- 2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-04
- Botanical Drug GM-XANTHO® Completes Phase I/IIa Trial for Atopic Dermatitis XANTHO BIOTECHNOLOGY CO., LTD. / 2026-06-04
- ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readines PROBIO TECHNOLOGY HK LIMITED. / 2026-06-04
- LIS TECH Showcases Regenerative Medicine and Bioprocessing Platform at BIO Asia–Taiwan 2026 LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- GeniCore Biotech Unveils Its AI-Powered Genimer™ Aptamer Platform LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- Medidata’s Digital Oversight Platform Empowers Pharma and CROs to Align with Next-Gen GCP MEDIDATA / 2026-06-02
- Medidata Powers Transformational Breakthroughs in Over 500 Global Clinical Trials with AI MEDIDATA / 2026-06-02
- Empowering eCOA to Deliver Flexible and Efficient Digital Solutions MEDIDATA / 2026-06-02
- Save the Date: LabWare Professional Seminar Coming This September! LABWARE TAIWAN CO., LTD. / 2026-05-29
- SimTissue® by Lyson: The One-Stop Phantom Solution for Advanced Surgical Simulation LYSON MEDICAL TECHNOLOGY / 2026-05-27